论文部分内容阅读
急性ST段抬高型心肌梗死(STEM I)是急性冠脉综合征中病死率和致残率最高的一种,药物再灌注治疗及急诊介入治疗仍然是STEM I主要治疗策略[1]。近期研究发现,急诊经皮冠状动脉介入治疗的时间与急性STEM I患者1年病死率相关[2]。本研究通过分析发病12 h内就诊的急性STEM I患者住院
Acute ST-segment elevation myocardial infarction (STEMI) is the highest mortality and morbidity in acute coronary syndromes. Drug reperfusion and emergency intervention are still the main treatment strategies for STEMI [1]. Recent studies have found that the duration of emergency percutaneous coronary intervention is associated with 1-year mortality in patients with acute STEM I [2]. This study analyzed hospitalizations of acute STEM I patients within 12 h of onset of illness